Marion Buck

707 total citations
25 papers, 566 citations indexed

About

Marion Buck is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Marion Buck has authored 25 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Marion Buck's work include Viral-associated cancers and disorders (11 papers), Lymphoma Diagnosis and Treatment (9 papers) and T-cell and Retrovirus Studies (4 papers). Marion Buck is often cited by papers focused on Viral-associated cancers and disorders (11 papers), Lymphoma Diagnosis and Treatment (9 papers) and T-cell and Retrovirus Studies (4 papers). Marion Buck collaborates with scholars based in Australia, Germany and Austria. Marion Buck's co-authors include Kenia G. Krauer, T B Sculley, Tom Sculley, Norbert Kienzle, James M. Flanagan, Wayne A. Schroder, John F. Hancock, Gillian R. Bushell, Nikolaus Mueller‐Lantzsch and Nicole Cloonan and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Oncogene.

In The Last Decade

Marion Buck

25 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marion Buck Australia 13 263 194 91 73 73 25 566
Meike Müller Germany 11 229 0.9× 151 0.8× 50 0.5× 90 1.2× 116 1.6× 17 662
Maria E. Ramos‐Niño United States 20 367 1.4× 186 1.0× 53 0.6× 137 1.9× 42 0.6× 44 1.2k
Chi‐Chen Fan Taiwan 19 423 1.6× 158 0.8× 50 0.5× 115 1.6× 36 0.5× 26 842
Sang Youn Hwang South Korea 17 260 1.0× 134 0.7× 88 1.0× 29 0.4× 50 0.7× 45 876
K. Callaghan Australia 6 157 0.6× 168 0.9× 43 0.5× 161 2.2× 21 0.3× 11 572
Qian An China 14 421 1.6× 143 0.7× 65 0.7× 30 0.4× 22 0.3× 37 645
Ana Paula Dias Demasi Brazil 17 333 1.3× 183 0.9× 27 0.3× 56 0.8× 36 0.5× 40 796
Seung Hee Kang South Korea 11 141 0.5× 87 0.4× 48 0.5× 72 1.0× 21 0.3× 30 553
Mitsunobu Sato Japan 13 157 0.6× 173 0.9× 39 0.4× 130 1.8× 36 0.5× 25 469
Michelle H. Townsend United States 13 278 1.1× 224 1.2× 21 0.2× 85 1.2× 35 0.5× 27 551

Countries citing papers authored by Marion Buck

Since Specialization
Citations

This map shows the geographic impact of Marion Buck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Buck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Buck more than expected).

Fields of papers citing papers by Marion Buck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion Buck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Buck. The network helps show where Marion Buck may publish in the future.

Co-authorship network of co-authors of Marion Buck

This figure shows the co-authorship network connecting the top 25 collaborators of Marion Buck. A scholar is included among the top collaborators of Marion Buck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marion Buck. Marion Buck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jonas, Daniel E, Sandra Reuter, Marion Buck, et al.. (2021). Evaluation of the BD Phoenix CPO detect panel for prediction of Ambler class carbapenemases. Scientific Reports. 11(1). 13150–13150. 10 indexed citations
2.
Leder, Christoph, Tushar Rastogi, Christian Peifer, et al.. (2021). Reducing Environmental Pollution by Antibiotics through Design for Environmental Degradation. ACS Sustainable Chemistry & Engineering. 9(28). 9358–9368. 49 indexed citations
3.
Liu, Tao, Traian V. Chirilă, Marion Buck, et al.. (2020). Transparent, Pliable, Antimicrobial Hydrogels for Ocular Wound Dressings. Applied Sciences. 10(21). 7548–7548. 4 indexed citations
4.
Reinhardt, Heike, Rainer Trittler, Stefan Wöhrl, et al.. (2017). Paving the Way for Dose Banding of Chemotherapy: An Analytical Approach. Journal of the National Comprehensive Cancer Network. 15(4). 484–493. 11 indexed citations
5.
Roberts, Matthew J., Renée S. Richards, Marion Buck, et al.. (2017). Seminal plasma enables selection and monitoring of active surveillance candidates using nuclear magnetic resonance-based metabolomics: A preliminary investigation. Prostate International. 5(4). 149–157. 14 indexed citations
6.
Roberts, Matthew J., Renée S. Richards, Suhail A.R. Doi, et al.. (2016). Prostate-based biofluids for the detection of prostate cancer: A comparative study of the diagnostic performance of cell-sourced RNA biomarkers. Prostate International. 4(3). 97–102. 8 indexed citations
7.
Forget, Aurélien, Neha Arya, Marion Buck, et al.. (2016). Nonwoven Carboxylated Agarose-Based Fiber Meshes with Antimicrobial Properties. Biomacromolecules. 17(12). 4021–4026. 31 indexed citations
8.
Harris, Janelle L., Renée S. Richards, Soon Lee, et al.. (2013). BMCC1 Is an AP-2 Associated Endosomal Protein in Prostate Cancer Cells. PLoS ONE. 8(9). e73880–e73880. 11 indexed citations
9.
Zenzmaier, Christoph, et al.. (2011). Elevated levels of Dickkopf-related protein 3 in seminal plasma of prostate cancer patients. Journal of Translational Medicine. 9(1). 193–193. 10 indexed citations
10.
Schroder, Wayne A., Marion Buck, Nicole Cloonan, et al.. (2007). Human Sin1 contains Ras-binding and pleckstrin homology domains and suppresses Ras signalling. Cellular Signalling. 19(6). 1279–1289. 87 indexed citations
11.
Buck, Marion, et al.. (2006). Epstein–Barr virus nuclear antigen 3A contains six nuclear-localization signals. Journal of General Virology. 87(10). 2879–2884. 12 indexed citations
12.
Krauer, Kenia G., et al.. (2003). The Epstein–Barr virus nuclear antigen-6 protein co-localizes with EBNA-3 and survival of motor neurons protein. Virology. 318(1). 280–294. 14 indexed citations
13.
Krauer, Kenia G., Andrew Burgess, Marion Buck, et al.. (2003). The EBNA- 3 gene family proteins disrupt the G2/M checkpoint. Oncogene. 23(7). 1342–1353. 44 indexed citations
14.
Sculley, T B, Marion Buck, Brian Gabrielli, Peter G. Parsons, & Kenia G. Krauer. (2002). A HISTONE DEACETYLASE INHIBITOR, AZELAIC BISHYDROXAMIC ACID, SHOWS CYTOTOXICITY ON EPSTEIN-BARR VIRUS-TRANSFORMED B-CELL LINES. Transplantation. 73(2). 271–279. 12 indexed citations
15.
Kienzle, Norbert, Marion Buck, Sharon L. Silins, et al.. (2000). Differential Splicing of Antigen-Encoding RNA Reduces Endogenous Epitope Presentation That Regulates the Expansion and Cytotoxicity of T Cells. The Journal of Immunology. 165(4). 1840–1846. 4 indexed citations
16.
Krauer, Kenia G., Marion Buck, & Tom Sculley. (1999). Characterization of the transcriptional repressor RBP in Epstein–Barr virus-transformed B cells. Journal of General Virology. 80(12). 3217–3226. 2 indexed citations
17.
18.
Kienzle, Norbert, T B Sculley, L M Poulsen, et al.. (1998). Identification of a Cytotoxic T-Lymphocyte Response to the Novel BARF0 Protein of Epstein-Barr Virus: a Critical Role for Antigen Expression. Journal of Virology. 72(8). 6614–6620. 41 indexed citations
19.
Mueller‐Lantzsch, Nikolaus, Marlies Sauter, Klaus Krämer, et al.. (1993). Human Endogenous Retroviral Element K10 (HERV-K10) Encodes a Full-Length Gag Homologous 73-kDa Protein and a Functional Protease. AIDS Research and Human Retroviruses. 9(4). 343–350. 77 indexed citations
20.
Buck, Marion, et al.. (1992). Expression of Epstein-Barr virus membrane antigen gp350/220 in E. coli and in insect cells. Virology. 191(1). 443–447. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026